Skip to main content
Valneva SE logo

Valneva SE — Investor Relations & Filings

Ticker · VLA ISIN · FR0004056851 LEI · 969500DIVIP5VKNW4948 PA Manufacturing
Open in API
Filings indexed 1,661 across all filing types
Latest filing 2025-10-06 Regulatory Filings
Country FR France
Listing PA VLA

About Valneva SE

https://valneva.com/

Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.

Recent filings

Filing Released Lang Actions
6-K
Regulatory Filings
2025-10-06 English
6-K
Regulatory Filings
2025-10-06 English
Valneva consolide sa position de trésorerie en refinançant sa dette auprès de Pharmakon Advisors et fait un point sur ses activités
Capital/Financing Update Classification · 100% confidence The document is a press release from Valneva SE announcing a new debt refinancing agreement with Pharmakon Advisors and providing an update on its 2025 financial outlook. It details the terms of the loan, the impact on the company's capital structure, and revised financial guidance due to regulatory developments. This fits the definition of a 'Capital/Financing Update' (CAP) as it focuses on fundraising and financing activities, while also containing elements of an earnings/financial outlook update.
2025-10-06 French
Valneva Strengthens Financial Position by Refinancing Debt with Pharmakon Advisors and Provides Business Updates
Capital/Financing Update Classification · 100% confidence The document is a press release from Valneva SE announcing a new debt financing facility (refinancing) and providing updated financial guidance for the 2025 fiscal year. Because the primary purpose is to announce a significant change in capital structure (debt refinancing) and provide updated financial outlooks, it falls under the 'Capital/Financing Update' category. It is not a full report, but rather a corporate announcement.
2025-10-06 English
VALNEVA Déclaration d’actions et de droits de vote : 30 septembre 2025
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document is a formal declaration of the total number of shares and voting rights for Valneva as of September 30, 2025. This type of disclosure is a standard regulatory requirement in France (AMF regulations) to inform the market of the capital structure and voting rights, which is essential for shareholders to calculate threshold crossings. It does not represent a change in capital (SHA), a director's dealing (DIRS), or a major shareholding notification (MRQ), but rather a periodic regulatory disclosure of the company's share capital composition. Therefore, it falls under the general regulatory filing category.
2025-10-06 French
VALNEVA Declaration of shares and voting rights: September 30, 2025
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal declaration of the total number of shares and voting rights for Valneva as of September 30, 2025. It explicitly references the calculation of voting rights for threshold crossing purposes and complies with AMF General Regulations. This type of disclosure is a standard regulatory requirement for listed companies to inform the market of their capital structure and voting rights, which falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2025-10-06 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.